The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
Global Toxin key players include Allergan, LIBP, Hugel, Ipsen, Medytox, etc. Global top five manufacturers hold a share about 90%.
Europe is the largest market, with a share over 10%, followed by APAC, and Middle East ＆ Africa, both have a share over 20%.
In terms of product, 50U is the largest segment, with a share about 55%. And in terms of application, the largest application is Cosmetic, followed by Medical, etc.
The global Toxin market was valued at US$ 4364 million in 2020 and is expected to reach US$ 8231.4 million by the end of 2027, growing at a CAGR of 9.8% during 2021-2027.
This report focuses on Toxin volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Toxin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Toxin Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
50U
100U
Others
Segment by Application
Medical
Cosmetic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Allergan
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
US World Meds
Hugel
Daewoong
Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
Global Toxin key players include Allergan, LIBP, Hugel, Ipsen, Medytox, etc. Global top five manufacturers hold a share about 90%.
Europe is the largest market, with a share over 10%, followed by APAC, and Middle East ＆ Africa, both have a share over 20%.
In terms of product, 50U is the largest segment, with a share about 55%. And in terms of application, the largest application is Cosmetic, followed by Medical, etc.
The global Toxin market was valued at US$ 4364 million in 2020 and is expected to reach US$ 8231.4 million by the end of 2027, growing at a CAGR of 9.8% during 2021-2027.
This report focuses on Toxin volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Toxin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Toxin Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
50U
100U
Others
Segment by Application
Medical
Cosmetic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Allergan
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
US World Meds
Hugel
Daewoong
Index1 Toxin Market Overview
1.1 Product Overview and Scope of Toxin
1.2 Toxin Segment by Type
1.2.1 Global Toxin Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 50U
1.2.3 100U
1.2.4 Others
1.3 Toxin Segment by Application
1.3.1 Global Toxin Sales Comparison by Application: (2021-2027)
1.3.2 Medical
1.3.3 Cosmetic
1.4 Global Toxin Market Size Estimates and Forecasts
1.4.1 Global Toxin Revenue 2016-2027
1.4.2 Global Toxin Sales 2016-2027
1.4.3 Toxin Market Size by Region: 2016 Versus 2021 Versus 2027
2 Toxin Market Competition by Manufacturers
2.1 Global Toxin Sales Market Share by Manufacturers (2016-2021)
2.2 Global Toxin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Toxin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Toxin Manufacturing Sites, Area Served, Product Type
2.5 Toxin Market Competitive Situation and Trends
2.5.1 Toxin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Toxin Players Market Share by Revenue
2.5.3 Global Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Toxin Retrospective Market Scenario by Region
3.1 Global Toxin Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Toxin Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Toxin Market Facts & Figures by Country
3.3.1 North America Toxin Sales by Country
3.3.2 North America Toxin Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Toxin Market Facts & Figures by Country
3.4.1 Europe Toxin Sales by Country
3.4.2 Europe Toxin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Toxin Market Facts & Figures by Region
3.5.1 Asia Pacific Toxin Sales by Region
3.5.2 Asia Pacific Toxin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Toxin Market Facts & Figures by Country
3.6.1 Latin America Toxin Sales by Country
3.6.2 Latin America Toxin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Toxin Market Facts & Figures by Country
3.7.1 Middle East and Africa Toxin Sales by Country
3.7.2 Middle East and Africa Toxin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Toxin Historic Market Analysis by Type
4.1 Global Toxin Sales Market Share by Type (2016-2021)
4.2 Global Toxin Revenue Market Share by Type (2016-2021)
4.3 Global Toxin Price by Type (2016-2021)
5 Global Toxin Historic Market Analysis by Application
5.1 Global Toxin Sales Market Share by Application (2016-2021)
5.2 Global Toxin Revenue Market Share by Application (2016-2021)
5.3 Global Toxin Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Toxin Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Allergan Toxin Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Ipsen
6.2.1 Ipsen Corporation Information
6.2.2 Ipsen Description and Business Overview
6.2.3 Ipsen Toxin Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Ipsen Toxin Product Portfolio
6.2.5 Ipsen Recent Developments/Updates
6.3 Medytox
6.3.1 Medytox Corporation Information
6.3.2 Medytox Description and Business Overview
6.3.3 Medytox Toxin Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Medytox Toxin Product Portfolio
6.3.5 Medytox Recent Developments/Updates
6.4 LIBP
6.4.1 LIBP Corporation Information
6.4.2 LIBP Description and Business Overview
6.4.3 LIBP Toxin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 LIBP Toxin Product Portfolio
6.4.5 LIBP Recent Developments/Updates
6.5 Merz Pharmaceuticals
6.5.1 Merz Pharmaceuticals Corporation Information
6.5.2 Merz Pharmaceuticals Description and Business Overview
6.5.3 Merz Pharmaceuticals Toxin Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Merz Pharmaceuticals Toxin Product Portfolio
6.5.5 Merz Pharmaceuticals Recent Developments/Updates
6.6 US World Meds
6.6.1 US World Meds Corporation Information
6.6.2 US World Meds Description and Business Overview
6.6.3 US World Meds Toxin Sales, Revenue and Gross Margin (2016-2021)
6.6.4 US World Meds Toxin Product Portfolio
6.6.5 US World Meds Recent Developments/Updates
6.7 Hugel
6.6.1 Hugel Corporation Information
6.6.2 Hugel Description and Business Overview
6.6.3 Hugel Toxin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hugel Toxin Product Portfolio
6.7.5 Hugel Recent Developments/Updates
6.8 Daewoong
6.8.1 Daewoong Corporation Information
6.8.2 Daewoong Description and Business Overview
6.8.3 Daewoong Toxin Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Daewoong Toxin Product Portfolio
6.8.5 Daewoong Recent Developments/Updates
7 Toxin Manufacturing Cost Analysis
7.1 Toxin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Toxin
7.4 Toxin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Toxin Distributors List
8.3 Toxin Customers
9 Toxin Market Dynamics
9.1 Toxin Industry Trends
9.2 Toxin Growth Drivers
9.3 Toxin Market Challenges
9.4 Toxin Market Restraints
10 Global Market Forecast
10.1 Toxin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Toxin by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Toxin by Type (2022-2027)
10.2 Toxin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Toxin by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Toxin by Application (2022-2027)
10.3 Toxin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Toxin by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Toxin by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Toxin Sales (K Vial) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Toxin Sales (K Vial) Comparison by Application (2021-2027)
Table 3. Global Toxin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Toxin Covered in This Study
Table 5. Global Toxin Sales (K Vial) of Key Manufacturers (2016-2021)
Table 6. Global Toxin Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Toxin Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Toxin Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Toxin Average Price (US$/Vial) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Toxin Manufacturing Sites and Area Served
Table 11. Manufacturers Toxin Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Toxin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Toxin as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Toxin Sales by Region (2016-2021) & (K Vial)
Table 16. Global Toxin Sales Market Share by Region (2016-2021)
Table 17. Global Toxin Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Toxin Sales by Country (2016-2021) & (K Vial)
Table 19. North America Toxin Sales Market Share by Country (2016-2021)
Table 20. North America Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Toxin Revenue Market Share by Country (2016-2021)
Table 22. Europe Toxin Sales by Country (2016-2021) & (K Vial)
Table 23. Europe Toxin Sales Market Share by Country (2016-2021)
Table 24. Europe Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Toxin Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Toxin Sales by Region (2016-2021) & (K Vial)
Table 27. Asia Pacific Toxin Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Toxin Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Toxin Revenue Market Share by Region (2016-2021)
Table 30. Latin America Toxin Sales by Country (2016-2021) & (K Vial)
Table 31. Latin America Toxin Sales Market Share by Country (2016-2021)
Table 32. Latin America Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Toxin Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Toxin Sales by Country (2016-2021) & (K Vial)
Table 35. Middle East and Africa Toxin Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Toxin Revenue Market Share by Country (2016-2021)
Table 38. Global Toxin Sales (K Vial) by Type (2016-2021)
Table 39. Global Toxin Sales Market Share by Type (2016-2021)
Table 40. Global Toxin Revenue (Million US$) by Type (2016-2021)
Table 41. Global Toxin Revenue Share by Type (2016-2021)
Table 42. Global Toxin Price (US$/Vial) by Type (2016-2021)
Table 43. Global Toxin Sales (K Vial) by Application (2016-2021)
Table 44. Global Toxin Sales Market Share by Application (2016-2021)
Table 45. Global Toxin Revenue (Million US$) by Application (2016-2021)
Table 46. Global Toxin Revenue Share by Application (2016-2021)
Table 47. Global Toxin Price (US$/Vial) by Application (2016-2021)
Table 48. Allergan Corporation Information
Table 49. Allergan Description and Business Overview
Table 50. Allergan Toxin Sales (K Vial), Revenue (Million US$), Price (US$/Vial) and Gross Margin (2016-2021)
Table 51. Allergan Toxin Product
Table 52. Allergan Recent Developments/Updates
Table 53. Ipsen Corporation Information
Table 54. Ipsen Description and Business Overview
Table 55. Ipsen Toxin Sales (K Vial), Revenue (Million US$), Price (US$/Vial) and Gross Margin (2016-2021)
Table 56. Ipsen Toxin Product
Table 57. Ipsen Recent Developments/Updates
Table 58. Medytox Corporation Information
Table 59. Medytox Description and Business Overview
Table 60. Medytox Toxin Sales (K Vial), Revenue (Million US$), Price (US$/Vial) and Gross Margin (2016-2021)
Table 61. Medytox Toxin Product
Table 62. Medytox Recent Developments/Updates
Table 63. LIBP Corporation Information
Table 64. LIBP Description and Business Overview
Table 65. LIBP Toxin Sales (K Vial), Revenue (Million US$), Price (US$/Vial) and Gross Margin (2016-2021)
Table 66. LIBP Toxin Product
Table 67. LIBP Recent Developments/Updates
Table 68. Merz Pharmaceuticals Corporation Information
Table 69. Merz Pharmaceuticals Description and Business Overview
Table 70. Merz Pharmaceuticals Toxin Sales (K Vial), Revenue (Million US$), Price (US$/Vial) and Gross Margin (2016-2021)
Table 71. Merz Pharmaceuticals Toxin Product
Table 72. Merz Pharmaceuticals Recent Developments/Updates
Table 73. US World Meds Corporation Information
Table 74. US World Meds Description and Business Overview
Table 75. US World Meds Toxin Sales (K Vial), Revenue (Million US$), Price (US$/Vial) and Gross Margin (2016-2021)
Table 76. US World Meds Toxin Product
Table 77. US World Meds Recent Developments/Updates
Table 78. Hugel Corporation Information
Table 79. Hugel Description and Business Overview
Table 80. Hugel Toxin Sales (K Vial), Revenue (Million US$), Price (US$/Vial) and Gross Margin (2016-2021)
Table 81. Hugel Toxin Product
Table 82. Hugel Recent Developments/Updates
Table 83. Daewoong Corporation Information
Table 84. Daewoong Description and Business Overview
Table 85. Daewoong Toxin Sales (K Vial), Revenue (Million US$), Price (US$/Vial) and Gross Margin (2016-2021)
Table 86. Daewoong Toxin Product
Table 87. Daewoong Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Toxin Distributors List
Table 91. Toxin Customers List
Table 92. Toxin Market Trends
Table 93. Toxin Growth Drivers
Table 94. Toxin Market Challenges
Table 95. Toxin Market Restraints
Table 96. Global Toxin Sales Forecast by Type (2022-2027) & (K Vial)
Table 97. Global Toxin Sales Market Share Forecast by Type (2022-2027)
Table 98. Global Toxin Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 99. Global Toxin Revenue Market Share Forecast by Type (2022-2027)
Table 100. Global Toxin Sales Forecast by Application (2022-2027) & (K Vial)
Table 101. Global Toxin Sales Market Share Forecast by Application (2022-2027)
Table 102. Global Toxin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 103. Global Toxin Revenue Market Share Forecast by Application (2022-2027)
Table 104. Global Toxin Sales Forecast by Region (2022-2027) & (K Vial)
Table 105. Global Toxin Sales Market Share Forecast by Region (2022-2027)
Table 106. Global Toxin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 107. Global Toxin Revenue Market Share Forecast by Region (2022-2027)
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Toxin
Figure 2. Global Toxin Market Share by Type in 2020 & 2027
Figure 3. 50U Product Picture
Figure 4. 100U Product Picture
Figure 5. Others Product Picture
Figure 6. Global Toxin Market Share by Application in 2020 & 2027
Figure 7. Medical
Figure 8. Cosmetic
Figure 9. Global Toxin Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Toxin Market Size 2016-2027 (US$ Million)
Figure 11. Global Toxin Sales 2016-2027 (K Vial)
Figure 12. Global Toxin Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Toxin Sales Share by Manufacturers in 2020
Figure 14. Global Toxin Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Toxin Players: Market Share by Revenue in 2020
Figure 16. Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Toxin Sales Market Share by Region (2016-2021)
Figure 18. Global Toxin Sales Market Share by Region in 2020
Figure 19. Global Toxin Revenue Market Share by Region (2016-2021)
Figure 20. Global Toxin Revenue Market Share by Region in 2020
Figure 21. United States Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Colombia Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Toxin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Toxin by Type (2016-2021)
Figure 45. Sales Market Share of Toxin by Application (2016-2021)
Figure 46. Sales Market Share of Toxin by Application in 2020
Figure 47. Revenue Share of Toxin by Application (2016-2021)
Figure 48. Revenue Share of Toxin by Application in 2020
Figure 49. Manufacturing Cost Structure of Toxin
Figure 50. Manufacturing Process Analysis of Toxin
Figure 51. Toxin Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
